Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefan Göring

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Bioorganic & Medicinal Chemistry Letters|September 16, 2014
Indolinone based LRRK2 kinase inhibitors with a key hydrogen bondStefan Göring, Jean-Marc Taymans, Veerle Baekelandt, et al.
Chemmedchem|February 14, 2015
Computer-guided design, synthesis, and biological evaluation of quinoxalinebisarylureas as FLT3 inhibitorsStefan Göring, Dennis Bensinger, Eva C Naumann, et al.
Journal of Medicinal Chemistry|October 27, 2015
Evaluation of Improved Glycogen Synthase Kinase-3α Inhibitors in Models of Acute Myeloid LeukemiaTheresa Neumann, Lina Benajiba, Stefan Göring, et al.
Bioorganic & Medicinal Chemistry Letters|May 28, 2013
Membrane anchoring γ-secretase modulators with terpene-derived moietiesEva Christine Naumann, Stefan Göring, Isabella Ogorek, et al.
ACS Chemical Neuroscience|August 4, 2012
Small molecule kinase inhibitors for LRRK2 and their application to Parkinson's disease modelsThomas Kramer, Fabio Lo Monte, Stefan Göring, et al.
Bioorganic & Medicinal Chemistry Letters|October 31, 2012
Modification of a promiscuous inhibitor shifts the inhibition from γ-secretase to FLT-3Ghislaine Marlyse Okala Amombo, Thomas Kramer, Fabio Lo Monte, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Bioorganic & Medicinal Chemistry Letters|September 16, 2014
Indolinone based LRRK2 kinase inhibitors with a key hydrogen bondStefan Göring, Jean-Marc Taymans, Veerle Baekelandt, et al.
Chemmedchem|February 14, 2015
Computer-guided design, synthesis, and biological evaluation of quinoxalinebisarylureas as FLT3 inhibitorsStefan Göring, Dennis Bensinger, Eva C Naumann, et al.
Journal of Medicinal Chemistry|October 27, 2015
Evaluation of Improved Glycogen Synthase Kinase-3α Inhibitors in Models of Acute Myeloid LeukemiaTheresa Neumann, Lina Benajiba, Stefan Göring, et al.
Bioorganic & Medicinal Chemistry Letters|May 28, 2013
Membrane anchoring γ-secretase modulators with terpene-derived moietiesEva Christine Naumann, Stefan Göring, Isabella Ogorek, et al.
ACS Chemical Neuroscience|August 4, 2012
Small molecule kinase inhibitors for LRRK2 and their application to Parkinson's disease modelsThomas Kramer, Fabio Lo Monte, Stefan Göring, et al.
Bioorganic & Medicinal Chemistry Letters|October 31, 2012
Modification of a promiscuous inhibitor shifts the inhibition from γ-secretase to FLT-3Ghislaine Marlyse Okala Amombo, Thomas Kramer, Fabio Lo Monte, et al.
Pageof 1